GLP-1

Semaglutide linked to higher risk of vision problems, FDA data analysis shows

by

The Sudden Spotlight on Semaglutide: Vision Risks in the Limelight Recent studies have raised concerns about the cardiovascular efficacy icon, Semaglutide, possibly linked to vision risks. Researchers from the University of Bern have scrutinized over 300,000 cases, revealing that Semaglutide may heighten the likelihood of vision impairment compared to other antidiabetic medications. This article delves … Read more

2025 Research | United States Diabetes Monitoring,

by

The Future of Diabetes Care in the United States The United States diabetes monitoring, treatment, and drug delivery market is on a trajectory of significant growth, predicted to reach a staggering $79 billion by 2031. This remarkable expansion is driven by several key factors, including the rising prevalence of diabetes and groundbreaking technological advancements aimed … Read more

Ohio State dietitians assess how fad diets stack the odds against social media users

by

Understanding the Influence of Social Media on Fad Diets Social media platforms like TikTok and Instagram have revolutionized how information about fad diets spreads. Short-form content-sharing has accelerated the adoption of these diet trends, often without scientific validation. As dietitians from Ohio State Institute attest, this phenomenon resembles a swift cascade, leaving consumers chasing instant … Read more

Unveiling leptin signaling in the DMH for metabolic effects

by

Unveiling the Complex Interplay Between Leptin Receptors and Metabolic Regulation In a groundbreaking study by Pennington Biomedical Research Center, scientists have delved deeper into how the brain regulates metabolism, body temperature, and energy utilization. Led by Dr. Heike Münzberg-Gruening, the research uncovers the roles of leptin receptors in the dorsomedial hypothalamus (DMH), shedding light on … Read more

Flavonoids help regulate gut hormones and show promise in managing type 2 diabetes

by

The Future of Flavonoids and Type 2 Diabetes Management Recent research highlights the transformative potential of flavonoids in managing type 2 diabetes (T2DM) by regulating gut hormones. As this plant-based compound gains traction, we’re poised to witness a shift in how we approach diabetes management. Enhancing Insulin Sensitivity Flavonoids, such as cyanidin-3-O-glucoside and baicalein, may … Read more

Next-gen weight-loss drugs will be here within 12 months

by

The Next Wave in Obesity and Diabetes Treatment The landscape of obesity and diabetes treatment is rapidly evolving with the development of advanced pharmacological solutions. The arrival of next-generation GLP-1 receptor agonists marks a significant milestone in medical science, with promising drugs like CagriSema and UBT251 poised to redefine treatment protocols. Breakthroughs in Weight Loss … Read more

The Unexpected Effects of GLP-1 Medications on Women’s Health

by

The Expanding Horizon: Future Trends in GLP-1 Receptor Agonists and Women’s Health Revolutionizing Metabolic and Hormonal Health GLP-1 receptor agonists (GLP-1 RAs) are no longer confined to glycemic control. Emerging trends suggest a broader application, particularly in metabolic and hormonal health. Recent studies highlight their potential in managing conditions like polycystic ovary syndrome (PCOS). For … Read more

Eli Lilly exec says weight loss pill could expand access to GLP-1s

by

The Future of Weight-Loss Treatments: Transitioning from Injections to Pills The landscape of weight-loss treatments is undergoing a significant transformation. Companies like Eli Lilly are pioneering efforts to make GLP-1 treatments more accessible worldwide with the introduction of an oral pill, orforglipron. This shift from injections to oral medications promises broader reach and adoption, according … Read more

New study confirms GLP-1 medications are safe for mental health in diabetes

by

Understanding the Future of GLP-1 Medication Safety The recent findings from a comprehensive study involving over 60 million patients have provided much-needed clarity on the safety of GLP-1 receptor agonists in managing type 2 diabetes. This pivotal research challenges previous safety concerns by indicating no increased risk of suicidality among users, compared to DPP-4 or … Read more

GLP-1s Not Linked With Higher Suicide Risk Compared to Other Diabetes Drugs

by

GLP-1s: Decoding Their Safety and Future in Diabetes Management Understanding GLP-1s and Their Popularity GLP-1 receptor agonists, or GLP-1s, have revolutionized the management of Type 2 Diabetes (T2D) and other chronic conditions, with approximately 12.5% of adults in the United States reporting usage. Recent studies emphasize their efficacy in glycemic control, cardiovascular health benefits, and … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]